Narrative medicine intervention for mental wellbeing in Juvenile Myositis and juvenile idiopathic arthritis
Authors' conclusion
Ninety-one percent participated in at least four of the six sessions, demonstrating feasibility. This exploratory study showed trend toward improved anxiety following narrative medicine session participation for those with elevated GAD-7.
Study context
- Population
- Patients aged 6 to 21 with juvenile dermatomyositis (JDM) and juvenile idiopathic arthritis (JIA)four groups by diagnosis and age
- Participants
- 12 vs 9
- Exposure
- Pre- vs post-narrative medicine intervention
- JDMn = 12
- JIAn = 9
- Outcome
- Feasibility (session participation)
Methodological detailspre- and post-intervention questionnaires, exploratory
- Pre- and post-intervention questionnaires
- Exploratory
Main finding
As reported in the abstract
Session participation
- Participated in ≥50% of sessions
- All patients
- Participated in ≥4 of the 6 sessions
- 91%
Observational data: associations, not effects.
Further findings
Pre- vs post-intervention questionnaires (PROMIS Depression, GAD-7, Childhood Attitude Towards Illness Scale, PHQ-8, CoVID Stress Scale)
- No statistically significant difference for any scales (Wilcoxon signed-rank test)
Anxiety and depression in those with elevated GAD-7 and PHQ-8 pre-intervention (sub-analysis)
- Trend towards improvement in anxiety
- P = 0.057
- No change for depression
- P = 0.171
Original publication
Narrative medicine intervention for mental wellbeing in Juvenile Myositis and juvenile idiopathic arthritis. Pediatr Rheumatol Online J. Published 31 May 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →